Summary of new drugs
September 10, 2010
THE Pharmaceutical Society of
Australia’s PAC10 is set to feature a
session titled ‘New Drugs – A
Summary of Recent Releases’ as
one of its last sessions on Oct 31.
Presented by Associate professor
Luis Roller from the Faculty of
Pharmacy and Pharmaceutical
Sciences at Monash Univery, the
session will look at modes of action,
evidence for efficacy, indications,
contraindications, adverse reactions,
drug interactions, dose forms, doses,
place in therapy and counselling
points of eight recently released or
about-to-be-released medicines.
Medicines canvassed will include
agomelatine (Valdoxan);
dapoxetine (Prilogy); a fixed-dose
combination of an opioid agonist
and an opioid antagonist,
oxycodone + naloxone (Targin);
paracetamol +caffeine (Panadol
Extra) as an enhanced analgesic;
nivibolol (Nebilet); lacosamide
(Vimpat); melatonin (Circadin) and
low-dose doxepin (Silenor).
Visit www.pac10.com.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 10 Sep 10To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 10 Sep 10
